Brief Research Report
Published on 28 Apr 2022
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
in Thoracic Oncology
![Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report](https://www.frontiersin.org/files/myhome article library/834704/834704_Thumb_400.jpg)
- 9,404 views
- 31 citations
Brief Research Report
Published on 28 Apr 2022
in Thoracic Oncology
Original Research
Published on 28 Apr 2022
in Thoracic Oncology
Original Research
Published on 27 Apr 2022
in Thoracic Oncology
Original Research
Published on 26 Apr 2022
in Thoracic Oncology
Original Research
Published on 22 Apr 2022
in Thoracic Oncology
Case Report
Published on 21 Apr 2022
in Thoracic Oncology
Review
Published on 20 Apr 2022
in Thoracic Oncology
Review
Published on 20 Apr 2022
in Thoracic Oncology
Original Research
Published on 14 Apr 2022
in Thoracic Oncology
Review
Published on 14 Apr 2022
in Thoracic Oncology
Review
Published on 12 Apr 2022
in Thoracic Oncology
Original Research
Published on 12 Apr 2022
in Thoracic Oncology
Review
Published on 08 Apr 2022
in Thoracic Oncology
Review
Published on 07 Apr 2022
in Thoracic Oncology
Review
Published on 06 Apr 2022
in Thoracic Oncology
Review
Published on 01 Apr 2022
in Thoracic Oncology